Needham Maintains Buy on Veracyte, Raises Price Target to $57
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
Needham analyst Mike Matson maintains Veracyte (NASDAQ:VCYT) with a Buy and raises the price target from $48 to $57.
Needham analyst Mike Matson maintains Veracyte (NASDAQ:VCYT) with a Buy and raises the price target from $48 to $57.